ESC 365 - Nearly nine year follow-up data on a leadless pacing system real life experience in comparison to data of the prospective trial

ESC2025 Premium Access

Nearly nine year follow-up data on a leadless pacing system real life experience in comparison to data of the prospective trial

Session: Cardiac rhythm disorders: devices, drugs, and outcomes

Topic: Device Treatment

Speaker: Doctor S. Winter (Cologne, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Stefan Winter

St. Vinzenz-Hospital, Cologne (Germany)

4 presentations

0 follower

5 more presentations in this session

Omega-3 Fatty Acids reduce rate and QT-interval, but increase electrical instability in cardiomyocytes

Speaker: Doctor C. Balbi (Zurich, CH)

HARBOR-AF: a multicentre, open-label, dose escalation study of the efficacy, safety, and tolerability of budiodarone for the treatment of subjects with paroxysmal atrial fibrillation

Speaker: Doctor C. Flynn (San Francisco Bay, US)

Guidelines and heartlines: evaluating procainamide use at a large academic medical center

Speaker: Doctor T. Ahuja (New York, US)

The advantages of using transtelephonic ECG monitoring device in outpatients with paroxysmal form of atrial fibrillation

Speaker: Mrs M. Hamidzoda (Dushanbe, TJ)

Trends in arrhythmia-related mortality among adults with hyperthyroidism in the U.S. from 1999 to 2020: A CDC WONDER analysis

Speaker: Miss O. Dairo (London, GB)

Access the full session

Cardiac rhythm disorders: devices, drugs, and outcomes

Speakers: Doctor S. Winter, Doctor C. Balbi, Doctor C. Flynn, Doctor T. Ahuja, Mrs M. Hamidzoda...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources